TXNRD1 and gastric neoplasm: In vivo, we found that BBSKE combined with oxaliplatin exhibited a synergistic inhibitory effect on gastric tumor growth, and effectively reduced the activity of TrxR1 in tumor tissues, which was consistent with the in vitro results.